Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Tanaka
Toshio
T
Osaka University, Osaka, Japan. ttanak@imed3.med.osaka-u.ac.jp
Kuwahara
Yusuke
Y
Shima
Yoshihito
Y
Hirano
Toru
T
Kawai
Mari
M
Ogawa
Masako
M
Arimitsu
Junsuke
J
Hagihara
Keisuke
K
Narazaki
Masashi
M
Ogata
Atsushi
A
Kawase
Ichiro
I
Kishimoto
Tadamitsu
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D016918:Arthritis, Reactive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D002951:Citrates; D005260:Female; D005708:Gallium; D006304:Health Status; D006801:Humans; D007596:Joints / Q000187:drug effects / Q000503:physiopathology; D011877:Radionuclide Imaging; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors* / Q000276:immunology; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D002951:Citrates; D019947:Receptors, Interleukin-6; D005708:Gallium; C103850:gallium citrate; C502936:tocilizumab